NOT ONE POSITIVE WORD ABOUT EFFICACY.
Instead of trying to make sense of A.F. dribbles
On BMRN: buy in the end of Sept.( was too shy to set PT, but all the others had it around $170...)
On SRPT: $27 PT, down from $33,set a couple of weeks ago.
And, he is brave enough to"explain" the latest developments.
Someone must have a gun to his skull:this is my guess.
Yes, statistics in BMRN press releases is one thing, detailed description of what the patients go through is something else( and injection side reaction is far from the only serious trouble the have to face with dris..).
Page 209 and on, and on in the Briefing document